| Report Title | Price | Action |
|---|---|---|
| Monoamine Oxidase (Adrenalin Oxidase or Epinephrine Oxidase or MAO or EC 1.4.3.4) - Drugs in Development, 2021
Monoamine Oxidase (Adrenalin Oxidase or Epinephrine Oxidase or MAO or EC 1.4.3.4) - Drugs in Development, 2021 Summary Monoamine Oxidase (Adrenalin ...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Leukocyte Immunoglobulin Like Receptor Subfamily B Member 2 (CD85 Antigen Like Family Member D or Immunoglobulin Like Transcript 4 or Monocyte/Macrophage Immunoglobulin Like Receptor 10 or CD85d or LILRB2) - Drugs in Development, 2021
Leukocyte Immunoglobulin Like Receptor Subfamily B Member 2 (CD85 Antigen Like Family Member D or Immunoglobulin Like Transcript 4 or Monocyte/Macroph...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Myeloproliferative Disorders (Oncology) - Drugs in Development, 2021
Myeloproliferative Disorders (Oncology) - Drugs in Development, 2021 Summary Myeloproliferative Disorders (Oncology) - Drugs in Development, 2021 pr...
Published: Apr-2021 | No. of Pages: 90
|
$ 2000 | |
| Maple Syrup Urine Disease (Genetic Disorders) - Drugs in Development, 2021
Maple Syrup Urine Disease (Genetic Disorders) - Drugs in Development, 2021 Summary Maple Syrup Urine Disease (Genetic Disorders) - Drugs in Developm...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Muscarinic Acetylcholine Receptor M3 (CHRM3) - Drugs in Development, 2021
Muscarinic Acetylcholine Receptor M3 (CHRM3) - Drugs in Development, 2021 Summary Muscarinic Acetylcholine Receptor M3 (CHRM3) - Drugs in Developmen...
Published: Apr-2021 | No. of Pages: 65
|
$ 3000 | |
| Monocarboxylate Transporter 1 (MCT 1 or Solute Carrier Family 16 Member 1 or SLC16A1) - Drugs in Development, 2021
Monocarboxylate Transporter 1 (MCT 1 or Solute Carrier Family 16 Member 1 or SLC16A1) - Drugs in Development, 2021 Summary Monocarboxylate Transport...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Lipase (EC 3.1.1.) - Drugs in Development, 2021
Lipase (EC 3.1.1.) - Drugs in Development, 2021 Summary Lipase (EC 3.1.1.) - Drugs in Development, 2021 provides in depth analysis on Lipase (EC 3.1...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Chemotherapy Effects (Toxicology) - Drugs in Development, 2021
Chemotherapy Effects (Toxicology) - Drugs in Development, 2021 Summary Chemotherapy Effects (Toxicology) - Drugs in Development, 2021 provides an ov...
Published: Apr-2021 | No. of Pages: 90
|
$ 2000 | |
| Turner Syndrome (Genetic Disorders) - Drugs in Development, 2021
Turner Syndrome (Genetic Disorders) - Drugs in Development, 2021 Summary Turner Syndrome (Genetic Disorders) - Drugs in Development, 2021 provides a...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| NAD+ ADP Ribosyltransferase (Poly Adenosine Diphosphate Ribose Polymerase or PARP or EC 2.4.2.30) - Drugs in Development, 2021
NAD+ ADP Ribosyltransferase (Poly Adenosine Diphosphate Ribose Polymerase or PARP or EC 2.4.2.30) - Drugs in Development, 2021 Summary NAD+ ADP Ribo...
Published: Apr-2021 | No. of Pages: 65
|
$ 3000 | |
| NADH Ubiquinone Oxidoreductase Chain 1 (NADH Dehydrogenase Subunit 1 or MT-ND1 or EC 7.1.1.2) - Drugs in Development, 2021
NADH Ubiquinone Oxidoreductase Chain 1 (NADH Dehydrogenase Subunit 1 or MT-ND1 or EC 7.1.1.2) - Drugs in Development, 2021 Summary NADH Ubiquinone O...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Liver X Receptor (LXR) - Drugs in Development, 2021
Liver X Receptor (LXR) - Drugs in Development, 2021 Summary Liver X Receptor (LXR) - Drugs in Development, 2021 provides in depth analysis on Liver ...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Bleeding And Clotting Disorders (Hematological Disorders) - Drugs in Development, 2021
Bleeding And Clotting Disorders (Hematological Disorders) - Drugs in Development, 2021 Summary Bleeding And Clotting Disorders (Hematological Disord...
Published: Apr-2021 | No. of Pages: 95
|
$ 2000 | |
| Primary Hyperoxaluria Type I (Genito Urinary System And Sex Hormones) - Drugs in Development, 2021
Primary Hyperoxaluria Type I (Genito Urinary System And Sex Hormones) - Drugs in Development, 2021 Summary Primary Hyperoxaluria Type I (Genito Urin...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Lanosterol 14 Alpha Demethylase (Sterol 14 Alpha Demethylase or Cytochrome P450 14DM or Cytochrome P450LI or Cytochrome P450 51A1 or CYPLI or CYP51A1 or EC 1.14.14.154) - Drugs in Development, 2021
Lanosterol 14 Alpha Demethylase (Sterol 14 Alpha Demethylase or Cytochrome P450 14DM or Cytochrome P450LI or Cytochrome P450 51A1 or CYPLI or CYP51A1 ...
Published: Apr-2021 | No. of Pages: 70
|
$ 3000 | |
| Neuronal Acetylcholine Receptor Subunit Beta 4 (CHRNB4) - Drugs in Development, 2021
Neuronal Acetylcholine Receptor Subunit Beta 4 (CHRNB4) - Drugs in Development, 2021 Summary Neuronal Acetylcholine Receptor Subunit Beta 4 (CHRNB4)...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Low Density Lipoprotein Receptor Related Protein 6 (LRP6) - Drugs in Development, 2021
Low Density Lipoprotein Receptor Related Protein 6 (LRP6) - Drugs in Development, 2021 Summary Low Density Lipoprotein Receptor Related Protein 6 (L...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Bone Disorders (Musculoskeletal Disorders) - Drugs in Development, 2021
Bone Disorders (Musculoskeletal Disorders) - Drugs in Development, 2021 Summary Bone Disorders (Musculoskeletal Disorders) - Drugs in Development, 2...
Published: Apr-2021 | No. of Pages: 95
|
$ 2000 | |
| Anemia of Chronic Disease (Hematological Disorders) - Drugs in Development, 2021
Anemia of Chronic Disease (Hematological Disorders) - Drugs in Development, 2021 Summary Anemia of Chronic Disease (Hematological Disorders) - Drugs...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| 23S Ribosomal RNA (23S rRNA) - Drugs in Development, 2021
23S Ribosomal RNA (23S rRNA) - Drugs in Development, 2021 Summary 23S Ribosomal RNA (23S rRNA) - Drugs in Development, 2021 provides in depth analys...
Published: Apr-2021 | No. of Pages: 70
|
$ 3000 |